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Abstract
We combined in silico, in vivo, and in vitro studies to gain insights into age-dependent changes in acute inflammation in
response to bacterial endotoxin (LPS). Time-course cytokine, chemokine, and NO2
2/NO3
2 data from ‘‘middle-aged’’ (6–8
months old) C57BL/6 mice were used to re-parameterize a mechanistic mathematical model of acute inflammation
originally calibrated for ‘‘young’’ (2–3 months old) mice. These studies suggested that macrophages from middle-aged mice
are more susceptible to cell death, as well as producing higher levels of pro-inflammatory cytokines, vs. macrophages from
young mice. In support of the in silico-derived hypotheses, resident peritoneal cells from endotoxemic middle-aged mice
exhibited reduced viability and produced elevated levels of TNF-a, IL-6, IL-10, and KC/CXCL1 as compared to cells from
young mice. Our studies demonstrate the utility of a combined in silico, in vivo, and in vitro approach to the study of acute
inflammation in shock states, and suggest hypotheses with regard to the changes in the cytokine milieu that accompany
aging.
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Introduction
Inflammation ensues upon acute biological stress such as
bacterial infection or tissue trauma [1]. In elderly individuals,
the inflammatory response becomes radically altered, and is often
accompanied by low grade, chronic, inflammation even in the
absence of external stimulus [2–4]. Indeed, the linkage between
inflammation and aging is close, prompting some authors to coin
the term ‘‘inflamm-aging’’ for this complex process [4]. ‘‘Inflamm-
aging’’ is associated with many functional alterations in both
innate and adaptive immunity [5,6]. Among the cellular compo-
nents of the innate immune response, macrophages secrete a wide
range of cytokines, chemokines and growth factors in response to
pathogens, bacterial toxins, and host-derived damage-associated
molecular pattern (DAMP) molecules [7,8]. The effect of age on
the production of these inflammatory mediators following
macrophage activation by stimuli such as Gram-negative bacterial
lipopolysaccharide (LPS) is not well defined [9–11].
To address the complexity of the acute inflammatory response
in vivo, we have constructed mechanistic mathematical models of
increasing complexity, using ordinary differential equations
(ODE), which encompass the dynamics of relevant cells and
cytokines as well as aspects of physiology and global tissue
damage/dysfunction [12–15]. These computational models are
capable of quantitative predictions, since they are calibrated to
circulating levels of inflammatory mediators in mice [12,16], rats
[17], and swine [18]. These models’ ability to predict mortality is
based on the incorporation of a global tissue damage/dysfunction
variable, which is both a marker of the adverse effects of
inflammation as well as a driver of further inflammation.
To address the effect of a chronic inflammatory perturbation on
inflammation in vivo, we have developed a methodology that
utilizes a combination of the mathematical model, automated
data-fitting algorithms, and both in vivo and in vitro data. We
previously utilized this approach to examine the controversial role
of LPS or bacterial translocation in trauma/hemorrhage-induced
inflammation [16]. Herein, we sought to use a similar approach to
gain insight into the alterations characteristic of inflammation in
aged mice. We hypothesized that we could obtain insights into
cellular-level changes characteristic of the aged inflammatory
response by examining the systemic responses of ‘‘middle-aged’’
mice, re-parameterizing our mathematical model for the levels of
circulating inflammatory analytes in these mice, and deriving
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insights into the cellular and intracellular changes that could lead
to these systemic alterations.
Materials and Methods
Ethics Statement
This study was performed in strict accordance with animal use
protocols following approval of the University of Pittsburgh
Institutional Animal Care and Use Committee (IACUC, protocol
number 13021433). These studies involved experimentally-in-
duced acute inflammation (endotoxemia; see below). Clinical signs
associated with this experimental paradigm include decreased
food/water intake, lethargy, anorexia, piloerection, and weight
loss. These pathophysiological changes mandated the classification
of this study as Category E of Pain/Distress. Euthanasia via
approved methods at a maximum of 90 min, or immediately upon
observation of the above clinical signs, was the primary means of
mitigating this degree of pain and distress.
Analgesics (opioids, steroids and non-steroidal anti-inflamma-
tory drugs) have profound effect on the cardiorespiratory system
and on the inflammatory response [19]. These effects include
blockade of cytokine response and acceleration of the progression
to shock [20]. In rodent models of sepsis, trauma-hemorrhagic
shock and hepatic ischemia/reperfusion, these drugs are also
known to significantly alter the inflammatory response and the
degree of organ damage [21]. Because the study proposed in this
protocol aim to unravel the mechanisms of inflammation-induced
organ injury through the generation of mathematical models,
administration of these drugs was contra-indicated, for they would
alter the course of inflammation and injury.
Experimental Endotoxemia and Culture of Resident
Peritoneal Cells
Male C57BL/6 mice were purchased from Charles Rivers
(Wilmington, MA) and were acclimatized in specific pathogen-free
conditions with 12-h light/dark facilities and received food and
water ad libitum. Plasma levels of inflammatory mediators from
young mice (n = 4, 8–12 weeks old, weighing 20–25 g) were used
for the initial calibration of the mathematical model, as described
elsewhere [12]. Plasma levels of inflammatory mediators from
‘‘Middle-aged’’ mice (n = 4, 6–8 months old, weighing 25–35 g)
were used to re-parameterize the mechanistic mathematical model
of acute inflammation that was originally calibrated for young
mice (see Mathematical model of inflammation). In these
initial studies, a limited number of plasma analytes (TNF-a, IL-6,
IL-10, and NO2
2/NO3
2; see Cytokine and NO2
2/NO3
2
analysis) were assessed. These initial re-calibration studies led
specific predictions regarding biological properties of young vs.
middle-aged macrophages (see Mathematical model of in-
flammation).
To validate these predictions in vitro, additional mice (n = 16 for
either young or middle-aged) were treated with sterile saline or
3 mg/kg LPS (Escherichia coli serotype O111:B4, catalog # L2630;
Sigma-Aldrich, St. Louis, MO) intraperitoneally for 90 min. The
animals were then euthanized by CO2 asphyxiation followed by
cervical dislocation. Blood samples were collected via cardiac
puncture and stored at 280uC until analysis for cytokine and
NO2
2/NO3
2.
To obtain resident peritoneal cells, the peritoneal cavity was
then flushed with cold saline (10 ml) via a large bore needle (18-
gauge), avoiding traumatic perforation of the bowel. The abdomen
was gently manipulated and the peritoneal fluid was aspirated
back using a 26-gauge needle. Peritoneal cells were collected,
washed and suspended in previously prepared DMEM (Dulbec-
co’s Modified Eagle’s Medium, Lonza, Walkersville, MD) cell
culture media containing 10% heat-inactivated FCS, 1 mM
glutamine, 50 U/ml penicillin and 50 mg/ml streptomycin.
Peritoneal cells (at a density of 26105 cells per well) from both
saline and LPS treated mice were plated on eight-well Lab TekTM
Chamber SlideTM tissue culture plates (Nalge Nunc International,
Rochester, NY) and allowed to attach in a humidified atmosphere
(5% CO2) for 2 h [22]. After adherence, the culture media was
replaced to remove the non-adherent cells and cell monolayers
(predominantly to be macrophages) were further incubated for
90 min. At the end of the experiment, the supernatants were
collected from each well and stored at 280uC until analysis. To
determine peritoneal cell count and viability, 10 mL of peritoneal
fluid were mixed with an equivalent volume of 0.1% trypan blue
pipetted into CountessH chamber slide, and analyzed using a
CountessH Automated Cell Counter (Life Technologies, Grand
Island, NY).
Qualitative Assessment of Cultured Peritoneal
Macrophages
At the end of the cell culture experiments the supernatants were
collected and the purity and overall viability of the resident
peritoneal macrophages were assessed. To do so, the wells were
washed with PBS and fixed with 70% ethanol. Eight random wells
from two chamber slides were selected from each group (young
and middle-aged mice) and macrophages were identified in each
well by characteristic morphology under light microscopy as [23].
Cytokine and NO2
2/NO3
2 Analysis
For the initial calibration of the mathematical model, plasma
samples from young mice (n = 4) treated with LPS in vivo were
collected at 0, 60 min, 90 min, 4 h, 12 h and 24 h and assayed for
IL-6, TNF-a, IL-10, and NO2
2/NO3
2. For the validation cohort
of mice, plasma samples and cell culture supernatants (n = 16 per
group for young and middle-aged mice, respectively) were assayed
for 20 cytokines using a multiplex bead immunoassay system
(LuminexTM, Millipore, Billerica, MA). The cytokine assays
included granulocyte-macrophage colony stimulating factor
(GM-CSF), keratinocyte-derived chemokine (KC; CINC-1;
CXCL1), interferon-c (IFN-c), IFN-c-inducible protein-10 (IP-
10; CXCL10), interleukin- (IL)-1a, IL-1b, IL-2, IL-4, IL-5, IL-6,
IL-10, IL-12 p40, IL-12p70, IL-13, IL-17, monocyte chemotactic
protein-1 (MCP-1; CCL2), monokine induced by gamma inter-
feron (MIG; CXCL9), macrophage inflammatory protein-1a
(MIP-1a), vascular endothelial growth factor (VEGF) and tumor
necrosis factor-a (TNF-a). Plasma and supernatant NO2
2/NO3
2
were measured by the nitrate reductase method using a
commercially available kit (Cayman Chemical, Ann Arbor, MI).
Statistical Analysis
All data are expressed as mean 6 SEM. Statistical analysis was
performed by Student’s t-test or Two-Way ANOVA followed by
Tukey post hoc or Holm-Sidak test as indicated using SigmaPlot
(Systat Software, San Jose, CA), with P,0.05 considered to be
significant.
Mathematical Model of Inflammation
The equations and specifications of the ‘‘young mouse-specific’’
mathematical model of inflammation have been described
elsewhere [12]. Briefly, we constructed a mathematical model of
acute inflammation that incorporates key cellular and molecular
components of the acute inflammatory response. The mathemat-
ical model consists of a system of 17 nonlinear ordinary differential
In Silico, In Vivo, and In Vitro Approaches to Aging
PLOS ONE | www.plosone.org 2 July 2013 | Volume 8 | Issue 7 | e67419
T
a
b
le
1
.
C
h
ar
ac
te
ri
st
ic
s
o
f
m
id
d
le
-a
g
e
d
sp
e
ci
fi
c
m
at
h
e
m
at
ic
al
m
o
d
e
ls
o
f
in
fl
am
m
at
io
n
.
M
o
d
e
l
P
a
ra
m
.
h
1
0
cp
h
n
1
0
km
d
km
p
e
kn
kn
p
e
x
cp
6
B
e
st
P
a
ra
m
.
D
ef
.
In
fl
u
e
n
ce
o
f
T
N
F
o
n
IL
-1
0
(H
ill
co
e
ff
ic
ie
n
t)
In
fl
u
e
n
ce
o
f
IL
-1
0
o
n
le
u
ko
cy
te
ac
ti
va
ti
o
n
(H
ill
co
e
ff
ic
ie
n
t)
R
at
e
o
f
ac
ti
va
ti
o
n
o
f
m
ac
ro
p
h
ag
e
s
d
u
e
to
d
am
ag
e
A
ct
iv
at
io
n
o
f
m
ac
ro
p
h
ag
e
s
b
y
LP
S
D
e
at
h
ra
te
o
f
n
e
u
tr
o
p
h
ils
A
ct
iv
at
io
n
o
f
n
e
u
tr
o
p
h
ils
b
y
LP
S
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
IL
-6
9s
in
fl
u
e
n
ce
o
n
T
N
F
C
h
a
n
g
e
in
M
id
d
le
-
a
g
ed
vs
.
Y
o
u
n
g
8
-f
o
ld
lo
w
e
r
5
-f
o
ld
lo
w
e
r
3
-f
o
ld
lo
w
e
r
9
-f
o
ld
h
ig
h
e
r
1
6
-f
o
ld
h
ig
h
e
r
5
-f
o
ld
h
ig
h
e
r
1
1
-f
o
ld
h
ig
h
e
r
M
o
d
e
l
1
5
P
ar
am
.
h
6
cp
k1
0
k1
0
m
0
kn
s6
xc
p
6
P
a
ra
m
.
D
ef
.
In
fl
u
e
n
ce
o
f
T
N
F
o
n
IL
-1
0
(H
ill
co
e
ff
ic
ie
n
t)
R
e
g
u
la
te
s
le
ve
ls
o
f
IL
-1
0
b
y
m
o
d
u
la
ti
n
g
p
ro
d
u
ct
io
n
/d
e
ca
y
ra
te
s
R
at
e
o
f
IL
-1
0
p
ro
d
u
ct
io
n
in
re
sp
o
n
se
to
o
th
e
r
cy
to
ki
n
e
s
D
e
at
h
ra
te
o
f
n
e
u
tr
o
p
h
ils
P
ro
p
e
n
si
ty
to
p
ro
d
u
ce
an
d
se
cr
e
te
IL
-6
at
re
st
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
IL
-6
9s
in
fl
u
e
n
ce
o
n
T
N
F
C
h
a
n
g
e
in
M
id
d
le
-
a
g
ed
vs
.
Y
o
u
n
g
3
-f
o
ld
lo
w
e
r
7
-f
o
ld
h
ig
h
e
r
8
4
-f
o
ld
h
ig
h
e
r
4
-f
o
ld
h
ig
h
e
r
3
6
-f
o
ld
h
ig
h
e
r
6
6
-f
o
ld
h
ig
h
e
r
M
o
d
e
l
1
6
P
ar
am
.
k6
n
o
K
n
kn
p
e
s6
xc
p
6
xm
6
P
a
ra
m
.
D
ef
.
In
fl
u
e
n
ce
o
f
N
O
2
2
/
N
O
3
2
o
n
IL
-6
D
e
at
h
ra
te
o
f
n
e
u
tr
o
p
h
ils
A
ct
iv
at
io
n
o
f
n
e
u
tr
o
p
h
ils
b
y
LP
S
P
ro
p
e
n
si
ty
to
p
ro
d
u
ce
an
d
se
cr
e
te
IL
-6
at
re
st
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
IL
-6
9s
in
fl
u
e
n
ce
o
n
T
N
F
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
IL
-6
9s
in
fl
u
e
n
ce
o
n
m
ac
ro
p
h
ag
e
ac
ti
va
ti
o
n
C
h
a
n
g
e
in
M
id
d
le
-
a
g
ed
vs
.
Y
o
u
n
g
2
6
-f
o
ld
h
ig
h
e
r
1
9
-f
o
ld
h
ig
h
e
r
6
-f
o
ld
h
ig
h
e
r
4
6
-f
o
ld
h
ig
h
e
r
5
0
-f
o
ld
h
ig
h
e
r
3
-f
o
ld
h
ig
h
e
r
M
o
d
e
l
1
8
P
ar
am
.
h
cp
6
h
cp
1
0
ki
n
o
sn
kn
p
e
s6
x6
cp
xm
p
e
P
a
ra
m
.
D
ef
.
In
fl
u
e
n
ce
o
f
IL
-6
o
n
T
N
F
(H
ill
co
e
ff
ic
ie
n
t)
In
fl
u
e
n
ce
o
f
IL
-1
0
o
n
T
N
F
(H
ill
co
e
ff
ic
ie
n
t)
In
fl
u
e
n
ce
o
f
n
e
u
tr
o
p
h
ils
o
n
iN
O
S
A
ct
iv
at
io
n
o
f
n
e
u
tr
o
p
h
ils
b
y
LP
S
P
ro
p
e
n
si
ty
to
p
ro
d
u
ce
an
d
se
cr
e
te
IL
-6
at
re
st
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
T
N
F’
s
in
fl
u
e
n
ce
o
n
IL
-6
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
in
fl
u
e
n
ce
o
f
LP
S
o
n
m
ac
ro
p
h
ag
e
ac
ti
va
ti
o
n
C
h
a
n
g
e
in
M
id
d
le
-
a
g
ed
/ v
s.
Y
o
u
n
g
1
.4
-f
o
ld
lo
w
e
r
4
1
-f
o
ld
lo
w
e
r
6
-f
o
ld
lo
w
e
r
2
8
-f
o
ld
h
ig
h
e
r
6
2
-f
o
ld
h
ig
h
e
r
7
3
-f
o
ld
h
ig
h
e
r
7
-f
o
ld
lo
w
e
r
M
o
d
e
l
1
9
P
ar
am
.
k6
n
kn
s1
0
xc
p
6
xm
d
P
a
ra
m
.
D
ef
.
In
fl
u
e
n
ce
o
f
n
e
u
tr
o
p
h
ils
o
n
IL
-6
D
e
at
h
ra
te
o
f
n
e
u
tr
o
p
h
ils
P
ro
p
e
n
si
ty
to
p
ro
d
u
ce
an
d
se
cr
e
te
IL
-1
0
at
re
st
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
IL
-6
9s
in
fl
u
e
n
ce
o
n
T
N
F
Sa
tu
ra
ti
o
n
co
n
st
an
t
fo
r
in
fl
u
e
n
ce
o
f
d
am
ag
e
o
n
m
ac
ro
p
h
ag
e
ac
ti
va
ti
o
n
C
h
a
n
g
e
in
M
id
d
le
-
a
g
ed
vs
.
Y
o
u
n
g
5
2
-f
o
ld
h
ig
h
e
r
8
-f
o
ld
h
ig
h
e
r
4
-f
o
ld
h
ig
h
e
r
3
0
-f
o
ld
h
ig
h
e
r
7
-f
o
ld
h
ig
h
e
r
M
o
d
e
l
p
ar
am
e
te
rs
(c
o
n
st
an
ts
)
ch
an
g
e
d
in
th
e
m
id
d
le
-a
g
e
d
sp
e
ci
fi
c
m
o
d
e
ls
ar
e
in
d
ic
at
e
d
,
al
o
n
g
w
it
h
th
e
ir
b
io
lo
g
ic
al
si
g
n
if
ic
an
ce
.
P
ar
am
.:
p
ar
am
e
te
r.
D
e
f.
:
d
e
fi
n
it
io
n
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
6
7
4
1
9
.t
0
0
1
In Silico, In Vivo, and In Vitro Approaches to Aging
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e67419
equations that describe the time course of these components.
Included in the model equations are two systemic variables that
represent mean arterial blood pressure and global tissue dysfunc-
tion and damage. ‘‘Global tissue damage/dysfunction’’ describes
the overall health of the organism, since the hallmark of all
physiological derangements accompanying sepsis and hemorrhag-
ic shock is the eventual, sequential failure of multiple organs.
Given the complexity of simulating individual organs, we
approximated this process by treating it as a gradual, ongoing
process occurring in the whole body and driven by inflammation.
Thus, elevated and unrecoverable tissue damage/dysfunction
served as a surrogate for death, while damage/dysfunction that
tended to return to baseline over time was a proxy for survival.
Each equation was constructed from known interactions among
model components as documented in the existing scientific
literature. The model and parameters were specified in three
stages. In the preliminary stage, the model was constructed so it
could reproduce qualitatively several different scenarios reported
in the literature. In this stage, experimentally determined values of
parameters such as cytokine half-lives were used when available.
In the second stage, the model was matched to our experimental
data by adjusting some of the parameters using our qualitative
understanding of the biological mechanisms together with the
dynamics of the model, to attain desired time course shapes. In the
third stage, the parameters were estimated by fitting the model to
the experimental data and using a stochastic gradient descent
algorithm that was developed by Immunetrics, Inc. (Pittsburgh,
PA) [12].
Adaptation of ‘‘Young-specific’’ Mathematical Model to
Account for Inflammation in Aging Mice
To recalibrate our mathematical model for data obtained in
‘‘middle-aged’’ mice we sought to find a minimal number of
parameter changes that would allow our original model to
reproduce accurately empirically observed time courses in aging-
mice. To prevent the optimizing algorithm from exploiting the
indirect action of unmeasured analytes, we attempted to confine
our search to those parameters that appear directly in the
equations of our measured analytes (IL-6, TNF-a, IL-10, and
NO2
2/NO3
2). Our procedure was to impose a limit of N changes,
run an optimizer bounded by this change limit, and evaluate the
fit. We evaluated these fits with respect to quantitative error totals
as well as general qualitative behavior. After evaluation, we
increased the number of parameters to be optimized and repeated
the process iteratively until sufficient fit quality was achieved. Each
optimization pass was allowed to choose randomly which N of the
candidate parameters to change. We performed numerous fits for
each N to account for the stochastic nature of our gradient descent
search. In order to obtain good fits with fewer than 10 changes, we
found it necessary to add the parameters of the (unmeasured)
activated macrophages (MA), activated neutrophils (NA), and
iNOS equations to our initial set of parameters to be fit [12].
When these parameters were included in the search, we found that
excellent fits could be obtained with fewer than eight parameter
changes. We also observed that eliminating any one of these
changes seems to result in a worse fit by both quantitative and
qualitative measures. This procedure yielded five parameter sets
with good fits to the data in middle-aged mice, with essentially
Figure 1. Data and model output for plasma cytokines and NO2
2/NO3
2 in young and middle-aged mice subjected to LPS. Young
(C57BL/6; n = 4 animals per time point) and middle-aged mice (n = 4 per time point) were injected with saline or 3 mg/kg LPS as described in Materials
and Methods. Plasma concentration as a function of time and age: (A) IL-6, (B) TNF-a, (C) IL-10 and (D) NO2
2/NO3
2. Symbols represent the mean 6
SEM (P,0.05, analyzed by Two-way ANOVA followed by Holm-Sidak test for plasma levels of IL-6 and IL-10). For young mice, the line indicates the
output of the baseline model of acute inflammation. For middle-aged mice, model re-calibration was carried out as described in the Materials and
Methods, yielding five models (colored lines). ‘‘Best Model’’ indicates the model giving the best overall fit to the data.
doi:10.1371/journal.pone.0067419.g001
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equal measures of error with respect to experimental data (data
not shown). The models exhibited similar behavior with regard to
model output and predictions presented herein, with various
‘‘tradeoffs’’ relative to a hypothetical perfect fit. Each parameter
set was based on similar, but not identical, changes to various
constants (Table 1). We show these models and indicate the one
judged as the best overall fit to the data by investigator consensus
(necessary given the overall similarity of the quantitative measures
used to distinguish among the models). Nonetheless, the model
output and predictions of all models are shown (Fig. 1, lines).
Results
Age-associated Changes in Inflammatory Mediators of
Endotoxemic Mice
Prior studies had suggested that older mice exhibit dysregulated
acute inflammation [24,25]. We confirmed this finding initially by
measuring plasma levels of IL-6 (Fig. 1A), TNF-a (Fig. 1B), IL-10
(Fig. 1C) and NO2
2/NO3
2 (Fig. 1D) in ‘‘young’’ (2–3 month old)
and ‘‘middle-aged’’ (6–8 month old) C57BL/6 mice subjected to
bolus intraperitoneal injection of 3 mg/kg LPS. Based on Two-
Way ANOVA, plasma levels of IL-6 and IL-10 were statistically
significantly higher (P,0.05) in middle-aged mice when compared
to similarly treated young mice, whereas NO2
2/NO3
2 was
statistically significantly higher (P,0.05) in young mice. In
addition, we discerned significant (P,0.05) age-time interactions
in the dynamics of IL-6 (at 60 min, 90 min, 4 h and 12 h), TNF-a
(at 60 and 90 min), IL-10 (at 60 min, 90 min, 4 h and 12 h), and
NO2
2/NO3
2 (at 4 h, 12 h and 24 h) (Fig. 2, symbols), when
comparing young vs. middle-aged mice post-LPS treatment.
Mathematical Modeling of Age-dependent Changes in
Circulating Inflammatory Mediators
We next hypothesized that mathematical modeling could help
us gain insights into the some of these complex changes in
circulating inflammatory mediators. We have previously devel-
oped a mechanistic mathematical model in which dynamics of
leukocytes and their products affect the whole-organism inflam-
matory response assessed as circulating levels of mediators, that we
calibrated using data from young C57BL/6 mice [12,16,26,27]
(see Materials and Methods). Using this base mathematical model, we
have previously developed a methodology by which to gain insight
into the complex changes in the acute inflammatory response of
gene-deficient animals (see Materials and Methods), which we utilized
to study the complex alterations in the acute inflammatory
response of CD14-deficient mice [16]. This methodology involves
measuring the levels of key circulating inflammatory mediators
(IL-6, TNF-a, IL-10, and NO2
2/NO3
2); re-parameterizing the
base mathematical model for these new data by generating an
ensemble of models with roughly equivalent fit to the data, as
assessed by an error function; and finally, determining the
consensus set of parameters that were altered in the automated
fitting process in order to fit these new data. Since these
parameters can be mapped to cellular- and molecular-level
biological processes (e.g. the degree to which LPS will induce
macrophages to produce TNF-a), this re-parameterization process
allows us to generate hypotheses regarding the underlying
differences in the inflammatory responses of the test animals (in
the current study, middle-aged C57BL/6 mice) vs. the control
animals (young C57BL/6 mice) based solely on systemic inflam-
matory mediator data.
Accordingly, we carried out the process described above (see
Materials and Methods). The resulting ensemble of five mathematical
models that fit the systemic IL-6, TNF-a, IL-10, and NO2
2/NO3
2
Figure 2. Difference in plasma cytokines and NO2
2/NO3
2 in young and middle-aged mice subjected to LPS. Young (C57BL/6; n = 3–8
animals per time point) and middle-aged mice (n = 4 per time point) were injected with saline or 3 mg/kg LPS as described in Materials and Methods.
Middle-aged mice had significantly higher levels of IL-6 (A), TNF-a (B), and IL-10(C) at 60 and 90 min when compared to young mice post-LPS
treatment (P,0.05, analyzed by Two-way ANOVA).
doi:10.1371/journal.pone.0067419.g002
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data in middle-aged mice suggested that, at the cellular level, aged
leukocytes produce higher levels of inflammatory cytokines,
particularly IL-6, IL-10 and to a lesser degree TNF-a at baseline
and in response to LPS. These models also predicted that
leukocytes from middle-aged mice undergo increased death as
compared to leukocytes from young mice (Table 1 and Fig. 1,
lines).
In vitro Validation of in silico Predictions
We next sought to validate these mathematical model predic-
tions by in vitro studies using resident macrophages harvested from
peritoneal cavities of young and middle aged mice that received
either intra-peritoneal saline or LPS. We first confirmed that
treatment with LPS for 90 min would result in a broad-based
induction of the inflammatory response in vivo. Accordingly, we
expanded our analysis to additional animals and additional
circulating inflammatory mediators (20 cytokines/chemokines as
well as NO2
2/NO3
2) (Table 2). In support of our initial findings,
middle-aged mice that were treated with LPS in vivo had
statistically significantly higher plasma concentrations of IL-6,
TNF-a, IL-10, MIG/CXCL9, MCP-1/CCL2, IL-1a, IL-17, and
IL-12p40 when compared to LPS treated young mice. However,
saline-treated (baseline) middle-aged mice had higher circulating
levels of GM-CSF, IL-1b, IL-2, IL-4, IL-12p40, and VEGF when
compared to saline-treated young mice. Moreover, saline-treated
young mice exhibited statistically significantly higher circulating
levels of NO2
2/NO3
2 when compared to saline treated middle-
aged mice (Table 2). Circulating plasma levels of IFN-c, IL-12p70,
IL-13, IL-17 and MIG were below the detection limit in both
young and middle-aged mice after either saline or LPS treatment.
One key prediction of our re-parameterized mathematical
model of inflammation was that leukocytes from middle-aged mice
would exhibit a higher production of inflammatory cytokines.
Resident macrophages from young and middle-aged mice were
obtained by peritoneal lavage and the supernatants of adherent
cells were assayed for the same 21 inflammatory mediators
described in Table 2. In support of the in silico predictions,
macrophages from saline-treated middle-aged mice produced
elevated levels of IL-6 (Fig. 3A), TNF-a (Fig. 3B), IL-10 (Fig. 3C)
and KC (Fig. 3D) when compared with similarly treated young
mice. However, macrophages from middle-aged mice subjected to
3 mg/kg LPS in vivo secreted statistically significantly elevated
levels of IL-6 (Fig. 3A), TNF-a (Fig. 3B), IL-10 (Fig. 3C), KC
(Fig. 3D), IL-2 (Fig. 3E), IL-4 (Fig. 3F) and VEGF (Fig. 3G) as
compared to similarly-treated macrophages from young mice. We
note that IL-2, IL-4, and VEGF are not included in the
mathematical model of inflammation [12].
Given the mathematically-predicted, age-dependent difference
in baseline and in vivo LPS-induced production of inflammatory
mediators, we next sought to determine if the actual degree of
LPS-induced stimulation of these mediators differed between
young and middle-aged mice. Accordingly, we calculated the fold
change difference among those mediators determined to be
statistically significantly different between young and middle-aged
mice. This fold change difference was calculated as follows:
In vivo LPS-induced levels of a given inflammatory mediator
Baseline saline treatmentð Þ -induced levels of a given inflammatory mediator :
Figure S1 shows fold change difference between young and
middle-aged mice. This analysis showed a statistically significant
(P=0.004) higher fold change difference for TNF-a in young mice
when compared to middle-aged mice, whereas there was no
statistical differences in the other inflammatory mediators.
Only one of the five middle aged-specific mathematical models
invoked a relatively minor effect on kinosn, a parameter governing
the influence of neutrophils on iNOS. Largely in agreement with
Table 2. Statistically significant plasma inflammatory mediators in both young and middle-aged mice after I.P saline or LPS
treatment.
Treatment Inflammatory Mediators Young (mean ± SEM) Middle-aged (mean ± SEM) P value (Student’s t-test)
Saline GM-CSF 0 20.263.5 P,0.001
IL-1b 0 21.262.9 P,0.001
IL-2 2.760.2 4.860.2 P,0.001
IL-4 2.860.2 5.560.4 P,0.001
IL-12p40 0 28.962.8 P,0.001
VEGF 1.260.2 2.860.3 P,0.001
NO2
2/NO3
2 36.961.9 22.161.1 P,0.001
LPS IL-6 14589.761583.9 33445.0867281.9 P= 0.004
TNF-a 93.6618.1 332.6663.7 P,0.001
IL-10 251.9640.3 458.9667.2 P= 0.016
MIG/CXCL9 100.9617.5 4099.46690.6 P,0.001
MCP-1 18869.163153.4 34142.964515.6 P= 0.012
IL-1a 48.166 124.560.4 P= 0.002
IL-17 0 5.560.9 P,0.001
IL-12p40 104.1614.3 183.2621.3 P= 0.006
NO2
2/NO3
2 54.764.3 34.662.3 P,0.001
GM-CSF 59.465.9 35.464.8 P= 0.005
Young and middle-aged mice (n = 16 each) were treated with either saline or LPS in vivo for 90 min., and circulating inflammatory mediators were assessed as described
in Materials and Methods.
doi:10.1371/journal.pone.0067419.t002
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the predictions of the mathematical model, there were no
statistically significant differences in NO2
2/NO3
2 levels in
macrophages isolated from young or middle-aged mice that
received either saline or LPS in vivo.
Another key prediction derived from the re-parameterization of
our mathematical model of inflammation was that leukocytes from
middle-aged mice would exhibit a shorter lifespan as compared to
leukocytes from young mice. Fig. 4 shows the total peritoneal cell
count (Fig. 4A) and cell viability (Fig. 4B) in young and middle-
aged mice after treatment with either saline or 3 mg/kg LPS
in vivo. In support of the in silico prediction, peritoneal cells from
young mice that were treated with saline or LPS in vivo had
statistically significantly higher cell counts when compared to
saline treated middle-aged mice (Fig. 4A). Peritoneal cells from
LPS-treated, but not saline-treated middle-aged mice exhibited
significantly lower cell viability when compared to cells from LPS-
treated young mice (Fig. 4B).
Discussion
Aging and the diseases that stem from it are consuming an ever-
larger portion of healthcare expenditures [28]. Recent genome-
wide association studies suggest that inflammation and cellular
senescence are common mechanisms in aging-associated diseases
[29]. Such studies raise the hypothesis that dysregulated inflam-
mation is at least part of the cause of aging-related diseases
[2,3,30,31], which has been supported by studies demonstrating
inflammation-counterbalancing mechanisms in centenarians [32].
It has also been hypothesized that an age-dependent increase in
pro-inflammatory tendency was favored in an environment in
which infection was prevalent, but that elevated inflammation is
predominantly detrimental in a modern world in which infection is
much less prevalent [33]. Importantly, these changes in inflam-
mation can be observed by middle age in both humans and
experimental animals, and are not merely a hallmark of the very
aged [34–36].
Monocytes and macrophages play central roles in the initiation
and resolution of inflammation in response to various insults [37],
including LPS-induced endotoxic shock [8]. Monocytes and
macrophages originate from a common myeloid progenitor cell
in the bone marrow and, under normal circumstances; monocytes
circulate in the bloodstream for a very short time before
undergoing spontaneous apoptosis [37,38]. In response to
differentiation factors, monocytes escape their apoptotic fate by
differentiating into tissue-resident macrophages [39]. Studies of
age-related differences in macrophage production of pro-inflam-
matory and anti-inflammatory cytokines in response to acute
stimulation in vitro have yielded conflicting results, highlighting the
complexity of inflammation in the aging process. Indeed, some
groups have reported a decrease in levels of IL-1b [40], IL-6 [41],
and TNF-a [42], while increases in levels of IL-1b, IL-6, and
TNF-a [43] have been reported by others.
Remarkable advances have been made in revealing molecular
mechanism underlying the acute inflammatory response, and yet
the complexity of this process – with its redundancy, positive and
negative feedback loops, and emergent system behavior that
cannot be readily discerned from a reductionist analysis of
individual pathways – makes inflammation the prototypical case
study for the application of systems and computational biology
[44,45]. These approaches, which include various ‘‘omics’’
methods as well as computational modeling, are being utilized to
address the complexity of inflammation in the aging process [46].
Accordingly, we hypothesized that we could gain cellular-level
insights into the altered inflammatory response that accompanies
aging using a mechanistic computational model that simulates
whole-animal inflammation as a consequence of inflammatory cell
activation by LPS [12,16,26,27]. We utilized mouse endotoxic
shock as a simplified paradigm of acute inflammation driven in
large part by monocyte/macrophages [8]. In essence, the variables
and parameters in our mathematical model represent different
aspects of cellular and sub-cellular biology of inflammation (e.g.
growth and decay rates of cells and cytokines), and is predicated on
the systemic spillover of inflammatory mediators into the
circulation. This latter feature – the connection between local
and systemic inflammation – has allowed us to calibrate this model
Figure 3. In vitro cytokine concentrations after in vivo treatment with either saline or LPS in young and middle aged mice. Young
(n = 16) and middle-aged mice (n = 16) were injected with saline or 3 m/kg LPS and peritoneal macrophages were harvested as described in Materials
and Methods. Middle-aged mice had significantly higher levels (*P,0.001 vs. young mice) of IL-6 (A), TNF-a (B), IL-10 (C) and KC (D) after in vivo
treatment with saline followed by in vitro treatment with culture media. IL-6 (A), TNF-a (B), IL-10 (C), KC (D), IL-2 (E), IL-4 (F) and VEGF (G)
concentrations were significantly higher (*P,0.001 vs. young mice) after in vivo LPS treatment followed by in vitro treatment with culture media.
doi:10.1371/journal.pone.0067419.g003
Figure 4. Total peritoneal cell count and cell viability. (A): Middle-aged mice that received in vivo LPS had significantly lower (*P,0.001) cell
count when compared to similarly treated young mice. (B): LPS-treated middle-aged mice had significantly lower (*P= 0.008) cell viability when
compared to LPS treated young mice.
doi:10.1371/journal.pone.0067419.g004
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using data on circulating inflammatory mediators. We have
previously utilized this mathematical model to show commonality
among the responses to LPS, surgical trauma, and trauma/
hemorrhage in young C57BL/6 mice [12]. Using this mathemat-
ical model, we have also gained insights into the characteristics of
systemic inflammation in young CD14-deficient mice vs. young
C57BL/6 controls, including the lack of a role for endogenous
LPS in trauma/hemorrhage-induced inflammation [16].
We reasoned that we could gain mechanistic insights into the
role of LPS in the inflammatory response by obtaining data on
circulating cytokines and NO2
2/NO3
2 in middle-aged mice, re-
calibrating our model, and determining which parameters were
changed relative to young mice. In initial studies, middle-aged
mice subjected to 3 mg/kg LPS exhibited higher circulating levels
of IL-6 and IL-10, and blunted NO2
2/NO3
2 when compared to
young mice, and in subsequent studies we verified that a broader
set of mediators was likewise altered in middle-aged mice. We then
re-calibrated the baseline (young C57BL/6 mouse-specific) math-
ematical model of inflammation using automated algorithms to
yield an ensemble of ‘‘aging-specific’’ models. These models were
interrogated as to changes in various parameters (corresponding to
biological mechanisms) compared to the ‘‘young-specific’’ model.
The ensemble of five mathematical models that best fit these data
suggested that aged leukocytes will produce elevated baseline levels
of IL-6 (and to a lesser degree, TNF-a), elevated LPS-induced
production of pro-inflammatory mediators and undergo increased
cell death as compared to young leukocytes, in agreement with the
literature [36,47].
To validate key in silico predictions about cellular-level changes
in acute inflammation that occur with aging, predictions which
were based on in vivo data (levels of circulating inflammatory
mediators), we carried out in vitro time-course studies on peritoneal
macrophages from C57BL/6 young and middle-aged mice. To
assess the universality of these predictions, and to gain further
insights into changes in acute inflammation that are characteristic
of aging, we surveyed a larger number of inflammatory mediators.
These in vitro results largely validated the mathematical model
prediction, as observed by elevated levels of IL-6, TNF-a, IL-10
and KC in resident peritoneal cells from middle-aged mice as
compared to cells from similarly-treated young mice. Though
aging can lead to reduced macrophage NO production [48], our
algorithms suggested at best a minor role for reduced expression of
iNOS by neutrophils, and this prediction was supported by the
lack of statistically significant differences in the production of
NO2
2/NO3
2 between young and middle-aged peritoneal macro-
phages. In addition, the statistically significant fold change
difference in TNF-a production suggests that macrophages in
young mice have greater responsiveness to LPS in vivo, with regard
to this key inflammatory cytokine, when compared to similarly
treated macrophages in middle-aged mice. Importantly, other
inflammatory mediators that differ significantly between young
and middle-aged mice are induced by LPS to roughly the same
extent. Another key in silico prediction was that the lifespans of
leukocytes derived from older mice would be shorter, a prediction
supported by in vitro cell qualitative assessment and cell viability as
well.
Our experimental studies, like our mathematical model, were
focused on cellular-level phenomena that drive systemic changes in
inflammatory mediators. In the present study, we therefore sought
to stimulate animals in vivo and then examine the responses in vitro
with the least further perturbation, in order to verify predictions
derived from the mathematical model. In separate studies we also
treated cultured macrophages with LPS in vitro (data not shown).
We observed a roughly similar increase in the levels of
inflammatory mediators when we added LPS in vitro to macro-
phages derived from mice that were previously treated in vivo with
saline (data not shown). Interestingly, in vitro LPS treatment of
macrophages derived from either young or middle-aged mice
previously treated in vivo with LPS resulted in decrease in levels of
inflammatory mediators, suggesting that the phenomenon of LPS
tolerance [49,50] occurs to an approximately equal degree in
young vs. middle-aged mice (data not shown).
We recognize that there are several limitations to the current
study. We note that there is discrepancy in the literature regarding
the definition of ‘‘middle-aged’’ mice. While some authors report
‘‘middle-age’’ as early as 8 month old [51,52], others have
considered 10–12 month as the appropriate range [53,54]. Yet
other investigators have gone beyond these age ranges and used
17–18 month mice to refer to ‘‘middle-age’’ [55,56]. In our study,
we used 6–8 month old mice to characterize the inflammatory
response associated with the upper age range for the mature adult
group, which is typically approximately 6 months [57]. We suggest
that our reported changes in the acute inflammatory response might best be seen
as characteristic of the continuum of aging. Another limitation of our
study lies with the cell type being studied. Like all mathematical
models, our model is, by necessity, an abstraction of the full scope
of the biology of acute inflammation. Thus, variables such as
‘‘macrophages’’ may represent multiple inflammatory cell types
(e.g. dendritic cells). Also important is the fact that our
mathematical model is based on a single compartment which
obeys the mean-field approximation, i.e. the whole organism is
abstracted as a ‘‘well-mixed bag’’; hence, peritoneal inflammatory
cells, chief among the being peritoneal macrophages, are the best
analog of the ‘‘macrophage’’ variable in our model. Another
limitation of our study is that while the mathematical model
predicted an increase in cell death of leukocytes in middle-aged
mice, it did not infer mechanisms by which cell death ensue in
aged leukocytes. In the current study, Trypan blue stain was used
to give a rough estimate of the viability of cultured macrophages
and to validate the mathematical model prediction. Future studies
will be aimed at understanding the mechanism of reduced
macrophage viability, in concert with mathematical models of
increased detail (e.g. including mechanistic details based on our
prior work on modeling apoptosis [58] and the role of NO in
modulating this form of programmed cell death [59]. In addition,
we also note that macrophage quantification by morphology alone
would yield rough estimation of the total macrophage count and
that techniques such as FACS and macrophage-specific markers
would be more accurate in macrophage quantification.
In conclusion, this study supports the concept of acute
inflammation in older mice as a complex, dysregulated state in
which imbalances in the cytokine network may lead to inappro-
priate, inadequate, or harmful responses. Moreover, our results
demonstrate the utility of a combined in silico, in vivo, and in vitro
approach to the study of acute inflammation.
Supporting Information
Figure S1 Fold change difference in inflammatory mediators
between young and middle-aged mice. Young mice had a
statistically significant (P=0.004) higher fold change in TNF-a
when compared to middle-aged mice (panel B), whereas no
statistical differences were observed in the other inflammatory
mediators.
(TIF)
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